GHOLAMREZA POURMAND

Current Position: Dean of Sina University Hospital

Tehran University of Medical Sciences

Contact Information

Academic Rank: Full Professor [Full GMC Registration (UK): 2876340]

Department: Urology

Address: Imam Khomeini St., Hassan Abad Sq., Sina Hospital

Tel (Office): (+9821) 6634 8560

Fax: (+9821) 6634 8561

E-mail:gh_pourmand@yahoo.com

Education

1992 – 1993

Fellowship in “Renal Transplantation”

Middlesex Hospital

London – UK

1984 – 1985

Fellowship in “Male Infertility & Urologic Oncology”

University of California Los Angeles (UCLA)

California - USA

1974 – 1978

Course of Specialty in “General Surgery & Urology”

Tehran University of Medical Sciences

Tehran – Iran

1965 – 1972

General Medicine (MD)

Ahvaz University of Medical Sciences

Ahvaz – Iran

Further Training Courses

August 2-4, 2010 Akademika Program about "Principles of Good Clinical Practice",

Turkey

May 15-18, 2006 Nanomedicine (Short Visit), Moscow – Russia

March 10-18, 2006 Nanomedicine (Short Course), Moscow – Russia

1998 Reproductive (Short Course), Brussels – Belgium

1992-1993 Laparoscopic Urology, King’s College School of Medicine and

Dentistry, UK

1992-1993 Renal transplantation, Middlesex Hospital, London – UK

1984 Male infertility, 3 months, U.C.L.A., U.S.A.

1984 Urology Oncology and Pediatric Urology, 6 months, Buffalo &

U.C.L.A., U.S.A.

1984 Renal Transplantation, 3 months, Guy’s Hospital, London – UK

1982 Neurogenic Bladder (Short Course), West Germany

1977 A Short Course of Urology & Nephrology, 3 months, Institute of

Urology& Nephrology, London – UK

Highlighted Educational/Professional Qualifications

The 3rd

Festival of Eternal Faces, 2006

Application of adipose tissue stem cells in urinary stress incontinence

Application of bone marrow stem cells: A pilot study

1800 kidney transplantations from live and deceased donors since 1983

Kidney transplantation (from live and deceased donors) and harvest since 1994

Founder of Urology Research Center, Tehran University of Medical Sciences

Professional Society Membership

1990 – Present European Association of Urology

1988 – Present American Urologic Association (Corresponding Member)

1988 – Present International Society of Urology (Iranian Delegate)

1972 – Present Iranian Medical Council

Work Experience

Executive Activities

2005 – Present: Secretary General of Clinical Research Committee, 11th

Festival of

National Research Center of Medical Sciences of Iran

2005 - Present: Dean of Sina University Hospital

2003 - Present: Director of Urology Research Center, Tehran University of Medical

Sciences

2003 – Present: Member of Nanotechnology Committee, Ministry of Health, Treatment

and Medical Education

2002 – Present: Iranian Councilor for Middle East Organ Transplantation Society

2001 – Present: Member of Clinical Sciences Committee, Ministry of Health, Treatment

and Medical Education

2001 – Present: Member of Medical Instruments Committee, Ministry of Health,

Treatment and Medical Education

2000 – Present: Consultant Member of Academy of Medical Sciences

1990 – Present: Member of Counseling Board of Medical Journal of Islamic Republic of

Iran

1990 – Present: Member of European Association of Urology

1989 – Present: Professor Delegate of SIU

1988 – Present: Corresponding member of American Urological Association

1980 – Present: Member of Supreme Medical Council, Ministry of Health

2010: Head of Specialized Committee of Surgical, Clinical Sciences, 16th

Razi Medical

Sciences Research Festival

2010: Member of Examining Board of Oral OSCE, 57th

Urology Board Examination

2005: Member of Distinguished Iranian Professors

2001: Clinical Sciences Research Programming Committee, Ministry of Health,

Treatment and Medical Education

1993 – 1997: Vice Chancellor for Research, Tehran University of Medical Sciences

1990 – 1992: Secretary General of Iranian Kidney Transplant Foundation

1990 – 1993: Member of American Fertility Society

1990 – 1992: Deputy Dean in Research, Tehran Medical Faculty

1988 – 1992: Chairman of Urology Department, Tehran University – Medical Faculty

1985 – 1993: Head of Urology Department, Sina University Hospital

1982 – 1985: Vice – Chairman of the Iranian Urological Association

Editorial Activities

Board of consultants member of "Archives of Iranian Medicine" (2012)

Editorial board member of "Iranian Journal of Reproductive Medicine" (2004)

Editorial board member of "Pejouhesh Journal of Faculty of Medicine" (2000)

Urology journal official of "Journal of Urology & Nephrology Research Center" and

"Iranian Urological Association" (2002)

Editor of "Acta Medical Iranica", Medical Journal of Tehran University (1990-1997)

Editorial board member of ActaMedicaIranica (1976)

Editorial board member of "Medical Journal of Tehran University of Medical Sciences"

(1976)

Editorial board member of "Iranian Journal of Reproductive Medicine"

Clinical Activities

1978 – Present

SINA UNIVERSITY HOSPITAL

Urologist

Tehran – Iran

1972 – 1974

AIR FORCE (Military Service)

1st Lieutenant – General Practitioner

Tehran – Iran

Teaching Service

1995 – Present

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

Full Professor

Tehran – Iran

1986 – 1994

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

Associate Professor

Tehran – Iran

1978 – 1986

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

Assistant Professor

Tehran – Iran

Thesis:

1. Allameh F, The association between androgenic hormone levels and the risk of

developing coronary artery disease (CAD), Specialty course of “Urology Surgery”,

Winter 2011 (Advisor)

2. Namdari F, Transdermal electromotive administration vs. intralesional injection of

verapamil and dexamethasone, Specialty course of “Urology Surgery”, Winter 2011

(Consultant)

3. Sajadi H, Evaluating erectile dysfunction treatment in andropause men considering

plasma testosterone levels in patients referred to Sina Hospital (2009-2010), Specialty

course of “Urology Surgery”, April 2011 (Advisor)

4. Shokoohideh V, Erectile dysfunction severity as a risk predictor for coronary artery

disease, Specialty course of “Urology Surgery”, 2010 (Advisor)

5. Hedayatifar SH, Evaluating clinical trend, results and outcomes of kidney transplant in

patients operated in Sina Hospital (1999-2008), Specialty course of “Urology Surgery”,

June 2010 (Advisor)

6. Mansouri S, Evaluating vaginal delivery urologic complications, Specialty course of

“Urology Surgery”, 2010 (Consultant)

7. Shaeikh-al-Eslami, Evaluating the effect of pentoxifilinon clinical signs and IL-6

decrease following torsion in male rats and comparing it to control group, General

Medicine, 2008 (Consultant)

8. Allameh F, Evaluating the effect of sex hormones in the incidence of prostate cancer,

General Medicine, 2009 (Advisor)

9. MohseniLangroudi M, Evaluating the effect of meat, garlic and tomato (licopen) on

prostate cancer, General Medicine, 2009(Advisor)

10. Ranjbar M, Evaluating the number of IFN-γ, IL-10, IL-17 cytokine secreting cells and

determining the percentage of subcategories of T-adjusting cells

(CD4+CD25+FoxP3+CD3+CD8+CD28-) in kidney transplant patients, "Immunology"

MSc. thesis, 2010 (Advisor)

11. Solgi GH, Effect of injecting donor's bone marrow cells on chimerism and renal

transplant outcome prognosis, "Immunology" PhD dissertation,2010 (Consultant)

12. Mahdiani M, Evaluating the relationship between hs-CRP serum level and renal graft

survival during the first post-kidney-transplant year in Sina Hospital in the second fall

and winter, 2007, Specialty course of “Urology Surgery”,2010 (Consultant)

13. Daneshpajouh A, Evaluating the treatment effects of intra-prostate toxin botulinum

Type A injection in prostate benign hyperplasia, Specialty course of “Urology Surgery”,

2009 (Consultant)

14. Shahnazari A, Evaluating predictive factors for the presence of a motile sperm in

testicles of non-obstructive azoospermic patients, Specialty course of “Urology

Surgery”, June 2010 (Advisor)

15. Hosseini, M, Evaluating the effect of corrected calcium levels on the incidence of

prostate cancer, General Medicine, 2010 (Advisor)

16. Shokouhideh V, Evaluating the relationship between erectile disorders and risk factors

in patients with coronary vascular disease among patients referred to the angiography

department of Day General Hospital (2008), Specialty course of “Urology Surgery”,

2010 (Advisor)

17. Family P, Ahmadi H, Evaluating the effect of vasectomy, sexual behaviors and

infections of the urinary system on the incidence of prostate cancer, General Medicine,

2008 (Advisor)

18. Abedi AR, Studying prostates cancer progress and prognosis based on PTEN, PSA and

Gleason Score, Specialty course of “Urology Surgery”, 2007 (Advisor)

19. Goudarzi M, Evaluating the effect of pentoxyphyllin on clinical signs and the

comparison of the reduction rate of TNF a after torsion in male rats and a control

group, General Medicine, 2007 (Consultant)

20. Khansari M, Evaluating the effect of estrogenic, progesterone and androgenic

recipients on progress and prognosis of bladder cancer and their relationship in

patients referred to Sina, Shariati and Imam Khomeini Hospitals (March 2001 –

October 2005), General Medicine, 2007 (Advisor)

21. Ghobadi E, Afshar M, Evaluating the effect of low power helium-neon laser on

secretion rate of effective cytokines of chronic transplantation pain in a culture gel,

General Medicine, 2007 (Advisor)

22. Salahi M, MohseniLangroudi M, Evaluating the effect of 17 risk factors on the

incidence of prostate cancer in Isfahan province, General Medicine, 2007 (Advisor)

23. Hosseini M, Evaluating the effect of modified amounts of calcium on the incident of

prostate cancer, General Medicine, 2007 (Advisor)

24. Sabouri B, Evaluating the effect of 16 risk factors on the incidence of prostate cancer,

General Medicine, 2007 (Advisor)

25. Ghorbani A, Searching mutations in agxt among Iranian patients suspicious of a type

of primary hyperoxaluria, Master’s Degree, 2006 (Consultant)

26. Naseh HR, Comparing urine facilitators, blockers and proteins of patients having renal

stones with healthy people (2002), Specialty course of “Urology Surgery”, 2005

(Advisor)

27. Mousavi SH, Comparing sexual impotency in groups including healthy people, patients

with renal dysfunction undergoing hemodialysis and kidney transplant recipients,

Specialty course of “Urology Surgery”, 2005 (Advisor)

28. Seraji A, The retrospective study of the role of microchimerism in graft survival of

female recipients who received kidney from males in Sina Kidney Transplant Research

Center (Sina Hospital) (1993-2002), Specialty course of “Urology Surgery”,

2003(Advisor)

29. Salem S, Evaluating the prevalence of infections during the 1st year following kidney

transplant in 100 cases in Sina Hospital (2002-2003), General Medicine, 2003(Advisor)

30. Jalalizadeh B, Evaluating the stability of chromatin in infertile patients with spinal and

vascular lesions (varicocell) and healthy males referred to Mirza Kouchak Khan and

Sina Hospitals and Kosar Medical Center (2002-2003), Specialty course of “Urology

Surgery”, 2003 (Advisor)

31. Sina A, The study of Y-chromosome microdeletion in patients referred to Sina and

MirzaKhouchak Khan Hospitals with non-obstructive idiopathic azoospermia (1999-

2000), Specialty course of “Urology Surgery”, 2002 (Advisor)

32. Jaladat H, Studying the prevalence of anti-sperm antibody (IgA, IgG) in serum and

semen of patients with varicocell referred to Sina Hospital in 2002 before and 6months

after varicocelectomy, Specialty course of “Urology Surgery”, 2002 (Advisor)

33. Baradaran N, Evaluating the effect of developing diabetes on the incidence of prostate

cancer, General Medicine, 2002 (Advisor)

34. Shoari M, Evaluating the frequency of diabetes mellitus or its increase following

kidney transplant and the how’s of its distribution according to some suggested factors

in patients operated in Sina Hospital (2007-2009), General Medicine, 2001 (Advisor)

35. Hashemian E, Evaluating the bone density in patients with kidney stone and comparing

the results with a control group, General Medicine, 2001 (Advisor)

36. Sadri M, Evaluating the effect of varicocelectomy on exact sperm morphology of

patients referred to Sina Hospital with varicocell (1998-2000), Specialty course of

“Urology Surgery”, 2000 (Advisor)

37. Haghshenas KH, Evaluating prognostic factors following Vedns surgery in

Venogenomicempote patients in Sina Hospital (1993-1998), Specialty course of

“Urology Surgery”, 1998 (Advisor)

38. ZohrehvandR, Comparing the quality of sperm test and the amount of sexual hormones

before and after kidney transplant in male receivers operated in Sina Hospital (1998-

1999), Specialty course of “Urology Surgery”, 1998 (Advisor)

39. Amidi A, Evaluating kidney damages by NAG and AAP urinary enzymes in patients

treated by ESWL, Specialty course of “Urology Surgery”, 1996 (Advisor)

40. Taheri M, Studying therapeutical effects of PygeumAfricanum essence on prostate

adenoma in Sina Hospital, Specialty course of “Urology Surgery”, 1996 (Advisor)

41. Afshar K, Evaluating serum lipoprotein changes in kidney transplant, Specialty course

of “Urology Surgery”, 1995 (Advisor)

42. Hematian MA, Evaluating kidney function after breaking the stones using renogram,

radionuclide and DTPA, Specialty course of “Urology Surgery”, 1995(Advisor)

43. KalhoriSH, The bacteriological evaluation of the central core of renal stones, Specialty

course of “Urology Surgery”, 1994 (Advisor)

44. Mokhtari GH, Urologic complications of gynecological surgeries, Specialty course of

“Urology Surgery”, 1993(Advisor)

45. Eshraghi B, The effect of diagnosis & treatment of papaverine in treating male

infertility, Specialty course of “Urology Surgery”, 1991 (Advisor)

46. Afshar K, Evaluating ESWL results performed in Sina Hospital ,General Medicine,

1991 (Advisor)

47. JamaliPaghal’e M, Pyeloplasty and comparing Tubating Vs. Tubeless surgical methods

in its treatment, Specialty course of “Urology Surgery”, 1991(Advisor)

48. Rafie B, Analyzing chemical renal stones (1987-88), General Medicine, 1988 (Advisor)

Research Interests:

Nanotechnology

Prostate Cancer

Kidney Transplantation

Research Projects:

Ongoing

Comparison of cut-off value for total prostate-specific antigen and free to total

prostate-specific antigen ratio with international standards in s multi-centric study

Study of erectile dysfunction treatment in andropause patients according to serum

testosterone level

Completed

Plasma adiponectin concentration before and after kidney transplantation

The evaluation of clinical and laboratory changes after varicocelectomy

Prostate cancer in Iran, risk factors

CMV in transplanted kidney

The role of microchimerism in graft survival of female recipients who received

kidney from males (aretrospective study), November 1993 – August 2002

“Erectile Dysfunction in patients with coronary artery disease andrisk of coronary

artery disease in patients with erectile dysfunction", is there any correlation?

The incidence of infection in the first year after renal transplantation in 100 patients

in Sina hospital

Evaluating the progression and outcome of prostate carcinoma with regard to PSA,

Gleason score and PTEN gene

The prevalence of urinarytract infection before and after simple prostatectomy

(TURP, open)

The population based evaluation of correlation between risk factors and prostate

cancer [Multi centric case–control study]

Evaluating the efficacy of Nandrolone (injectable androgen)in decreasing

bothersome symptoms after surgery for BPH

The evaluation of progression of prostate carcinoma based on Gleason score and

pathologic stage

Study and comparison of effects of living donor bone marrow cells infusion on

kidney recipient and graft survival with control group.

Publications:

Articles

English

1. Mehrsai AR, Namdari F, Salavati A, Dehghani S, Allameh F, Pourmand G. Comparison

of transdermal electromotive administration of verapamil and dexamethasone versus

intra-lesional injection for Peyronie's disease. Andrology, 1(1):129-32, January 2013

[Epub: October 23, 2012]

2. Pourmand G, Allameh F, Mohammad K, Dehghani S, Pourmand B, Mehrsai AR,

Hosseini SH. Prostate cancer predicting factors: a preliminary report from Tehran.

Urology Journal, 9(4):667-72, Fall 2012

3. Ranjbar M, Solgi G, Mohammadnia M, Nikbin B, Pourmand G, Ansaripour B,

Amirzargar A. Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-

17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with

donor cells infusion. Clin Exp Nephrol., August 2012

4. Aghamir SM, Salavati A, Aloosh M, Farahmand H, Meysamie A, Pourmand G.

Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years:

a randomized clinical trial. J Endourol., 26(6):621-4, June 2012 [Epub: January 4, 2012]

5. Akbari MT, Behjati F, Pourmand G, Asbagh FA, Kachoui MA. Cytogenetic

abnormalities in 222 infertile men with azoospermia and oligospermia in Iran: Report

and review. Indian J Hum Genet., 18(2):198-203, May 2012 [Epub: October 23, 2012]

6. Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar A. Clinical relevance of pre

and post-transplant immune markers in kidney allograft recipients: Anti-HLA and

MICA antibodies and serum levels of sCD30 and sMICA. Transplant Immunology,

26(2-3):81-7, March 2012

7. Hadadi A, Pourmand G, Mehdipour-Aghabagher B. Unilateral testicular tuberculosis:

Case report. Andrologia, 44(1):70-2, February 2012 [Epub: May 26, 2011]

8. Pourmand G, Ramezani R, Sabahgoulian B, Nadali F, Mehrsai AR, Nikoobakht MR,

Allameh F, Hossieni SH, Seraji A, Rezai M, Haidari F, Dehghani S, Razmandeh R,

Pourmand B. Preventing unnecessary invasive cancer-diagnostic tests: changing the

cut-off points. Iranian J Publ Health, 41(2): 47-52, February 2012

9. Pourmand G, Dehghani S, Saraji A, Khaki S, Mortazavi SH, Mehrsai A, Sajad H.

Relationship between post-kidney transplantation antithymocyte globulin therapy and

wound healing complications. Int J Org Transplant Med, Vol. 3 (2), 2012

10. Solgi G, Mytilineos J, Gadi V, Paul B, Pourmand G, Mehrsai A, Nikbin B, Amirzargar

AA. Donor-derived peripheral mononuclear cell DNA is associated with stable kidney

allograft function: a randomized controlled trial. Chimerism, 2(4):102-10, October –

December 2011(doi: 10.4161/chim.2.4.19095)

11. Salsabili N, Mirfakhraei Reza, Montazeri M, Ataei M, Yaghmaei P, Pourmand G.

Gonadotropin and Testosterone hormone’s serum levels and partial deletions in the

AZFc region in Iranian oligozoospermia infertile males. Health, 3 (9): 566-570,

September 2011

12. Razeghi E, Shafipour M, Ashraf H, Pourmand G. Lipid disturbances before and after

renal transplant. Exp Clin Transplant., 9 (4): 230-5, August 2011 [PMID:21819366]

13. Mohammadnia M, Solgi G, Ranjbar M, Shahrestani T, Edalat R, Razavi A, Nikbin B,

Pourmand G, Amirzargar M, Sarafnejad A, Amirzargar AA. Serum levels of

interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ

cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft

recipients after donor bone marrow cell infusion. Transplant Proceedings, 43(2):495-9,

March 2011 (doi: 10.1016/j.transproceed.2011.01.005)

14. Salem S, Salahi M, Mohseni M, Mehrsai AR, Jahani Y, Pourmand G. Major dietary

factors and prostate cancer risk: A prospective multi-cancer case-control study.

Nutrition & Cancer, 00 (0): 1-7 ,November 22, 2010 & Nutr Cancer, 63(1):21-7, January

2011

15. Pourmand G, Solgi GH. Augmentation of chimerism by donor bone marrow cells

infusion in kidney allograft recipients. European Urology Supplements, 10 (2): 134,

2011

16. Mirfakhraie R, Kalantar SM, Mirzajani F, Montazeri M, Salsabili N, Houshmand M,

Hashemi-Gorji F, Pourmand G. A Novel Mutation in the Transactivation-Regulating

Domain of the Androgen Receptor in a Patient with Azoospermia. J Androl., December

2, 2010 [PMID:21127309]

17. Ahmadi H, Allameh F, Baradaran N, MontaserKouhsari L, Bazargan Hejazu SH, Salem

S, Mehrsai AR, Pourmand G. Circulating sex hormones play no role in the association

between sexual activity and the risk of prostate cancer .J Sex Med, November 22, 2010

(doi: 10.1111/j.1743-6109.2010.02115.x.) [PMID:21091879]

18. Razeghi E, Heydarian P, Amerian M, Pourmand G. The risk factors for diabetes

mellitus after kidney transplantation. Saudi J Kidney Dis Transpl., 21(6): 1038-1043,

November 21, 2010 [PMID:21060170]

19. Mirfakhraie R, Mirzajani F, Kalantar M, Montazeri M, Salsabili N, Pourmand G,

HoushmandM. High prevalence of AZFb microdeletion in Iranian patients with

idiopathic non-obstructive azzospermia.Indian J Med Res. P. 256-270, September 2010

20. Pourmand G, Seraji A, Dehghani S, Mehrsai A, Nikoobakht M, Talibnajad M, Razeghi

E, Rahbar M, Hosseini H, Pourmand N, Poumand SH, Zahedikia M, Porhussein M,

Heidari F. Should post-kidney transplantation hyperlipidemia considered a risk factor

for graft function? International Journal of Organ Transplantation Medicine. Vol. 1, No.

3, July 2010

21. Nikoobakht M, Daneshpajooh A, Ahmadi H, Namdari F, Rezaeidanesh M, Amini S,

Pourmand G. Intraprostatic botulinum toxin type A injection for the treatment of

benign prostatic hyperplasia: Initial experience with Dysport. Scand J

UrolNephrol.,44(3):151-7, April 2010[PMID:20201752]

22. Salem S, Mehrsai A, Zartab H, Shahdadi N, Pourmand G. Effect of Penile-Extender

Device in Increasing Penile Size in Men with Shortened Penis: Preliminary Results.

Urol Res., April 2010[Epub: December 17, 2010; PMID:20016885]

23. Solgi G, Pourmand G, Mehrsai A, Taherimahmoudi M, Nicknam MH, Ebrahimi Rad

MR, Seraji A, Asadpoor A, Ansaripor B, Nikbin B, Amirzargar A. Anti-HLA antibodies

and kidney allograft outcomes in recipients with donor bone marrow cell infusion. Iran

J Immunol., 7(1):18-29, March 2010[PMID:20371916]

24. Pourmand G, Abedi AR, Karami AA, Khashayar P, Mehrsai AR. Urinary infection

before and after prostatectomy. Saudi J Kidney Dis Transpl., 21(2):290-4, March

2010[PMID:20228515]

25. Nikoobakht M, Shahnazari A, Rezaeidanesh M, Mehrsai A, Pourmand G. Effect of

Penile-Extender Device in Increasing Penile Size in Men with Shortened Penis:

Preliminary Results. J Sex Med., January 19, 2010 [PMID:20102448]

26. Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan-Pezeshki M, Pourmand G.

Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med.,

December 06, 2009 [Epub: September30, 2009; PMID:19796020]

27. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V, Pourmand G,

Mohagheghi MA, Abdollahzade S, Mousavi-Jarrahi A. Antibody response to

pneumococcal capsular polysaccharide vaccination in patients with chronic kidney

disease. Eur Cytokine Netw.,20(2):69-74, June 2009 [PMID:19541592]

28. Mehrsai A, Afsharpad M., Afsharpad MA, Mohydin M, Ansari B, Pourmand G, Nikbin

B. The effect of low-level helium-neon (HeNe) laser radiation on the secretion of

cytokines that promote chronic graft rejection – An in vitro study. Medical Laser

Application, March 2009

29. Pourmand, G. Anabolic-androgenic steroid effects on early morbid symptoms after

open prostectomy: A pilot study. Aging Male. 11 (3): 123-7, September 2008

[PMID:18821287]

30. Pourmand, G. The effect of successful renal transplantation on erectile dysfunction.

The Journal of Urology. Vol. 179,No. 4,Supplement:691, May 21, 2008

31. Pourmand G. Extracorporeal shock wave lithotripsy and its effect on renal function

assessed by 99m Technetium Dethylene-Tiamine-Penta aceticacid Scintigraphy. The

Journal of Urology. Vol. 179,No. 4,Supplement:464, May 20, 2008

32. Karimianpour N, Mousavi-Shafaei P, Ziaee AA, Akbari MT, Pourmand G, Abedi A,

Ahmadi A, AfshinAlavi H. Mutations of RAS gene family in specimens of bladder

cancer. Urol J., 5(4):237-42, Fall 2008 [PMID:19101897]

33. Pourmand G, Salem S, Moradi K, Nikoobakht MR, Tajik P, Mehrsai A. Serum Selenium

level and prostate cancer: a case-control study. Nutrition & Cancer. 60 (2): 171 – 176,

2008[PMID:18444148]

34. Pourmand, G. Extracorporeal shock wave lithotripsy in adults: results and short-term

complications. EurUrol Suppl., 7(3):81, 2008

35. Pourmand G. Infectious complications after kidney transplantation: a single-center

experience. Transpl Infect Dis., 9(4):302-9, December 2007

36. Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, Roshani A,

Kheirollahi A, Kalantar E, Baradaran N, Saboury B, Allameh F, Karami A, Ahmadi H,

Jahani Y. The Risk Factors of Prostate Cancer: A Multicentric Case-Control study in

Iran. Asian Pacific Journal of Cancer Prevention, 8(3):422-8, July – September 2007

[PMID: 18159981]

37. Pourmand G. The risk factors and laboratory diagnostics for post renal transplant

Tuberculosis: a case-control, country-wide study on definitive cases. Transpl Infect Dis.

Jul 26, 2007

38. Pourmand G. Does donor nephron mass have any impact on graft survival?

Transplant Proc., 39(4):914-6, May 2007

39. Pourmand G. Microchimerism and renal transplantation: doubt still

persists.Transplant Proc., 39(4):948-50, May 2007

40. Pourmand G. Clinical manifestation, laboratory findings, and the response of

treatment in kidney transplant recipients with CMV infection. Transplant

Proc.,39(4):993-6, May2007

41. Pourmand G. Does renal transplantation improve erectile dysfunction in

hemodialysed patients? What is the role of associated factors? Transplant

Proc.,39(4):1029-32, May2007

42. Pourmand, G. Pelvic nerve neuropathy after kidney transplantation. Transplant Proc.,

39(4):1108-10, May 2007

43. Pourmand G. Pharmacokinetics, efficacy, and safety of Iminoral compared with

Neoral in healthy volunteers and renal transplant recipients. Transplant

Proc.,39(4):1214-8, May2007

44. Pourmand G, Ziaee AA, Abedi AR, Mehrsai A, Alavi HA, Ahmadi A, Saadati HR. Role

of PTEN gene in progression of prostate cancer. Urology Journal.,4(2):95-100, Spring

2007[PMID: 17701929]

45. Mehrsai A, Djaladat H, Salem S, Jahangiri R, Pourmand G. Outcome of buccal

mucosal graft urethroplasty for long and repeated stricture repair. Urology, 69(1):17-

21,Discussion 21, January 2007[PMID: 17270600]

46. Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH,

Nourijelyani K. Comparison of urinary proteins in calcium stone formers and healthy

individuals: A case- control study, UrologiaInternaionalis,76(2):163-8, 2006[PMID:

16493220]

47. Pourmand G. Selective evaluation of two urinary enzymes (NAG and AAP) before and

after unilateral shock wave lithotripsy. ActaMedicaIranica, Vol 44, No 5,: 299-305,2006

48. Djaladat H, Mehrsai A, Rezazade M, Djaladat Y, Pourmand G. Varicocele and

Antisperm Antibody: fact or fiction? Southern medical Journal, 99(1):44-7, January

2006[PMID: 16466121]

49. Djaladat H, Mehrsai A, Saraji A, Moosavi S, Djaladat Y, Pourmand G. Suprapubic

prostatectomy with a novel catheter. J Urol., 175(6):2083-6, June 2006[PMID: 16697808]

50. Pourmand G. Improvement of erectile dysfunction after kidney transplantation, The

role of the associated factors.Urology Journal Vol 3, No 4, Autumn 2006: 240-244

51. Mousavi S, Mehrsai A, Nikoobakht M, Abedi AR, Salem S, Pourmand G. A Giant

congenital posterior urethral diverticulum associated with renal dysplasia. Urol J.,

3(4):247-9, Autumn 2006[PMID: 17559051]

52. Pourmand G. Post transplant infectious complications: A prospective study on 142

kidney allograft recipients. Urology Journal, Vol. 3, No. 1, 23-31, 2006

53. Salsabili N, Mehrsai A, Jalalizadeh B, Pourmand G, Jalaie S. Correlation of sperm

nuclear chromatin condensation staining method with semen parameters and sperm

functional tests in patients with spinal cord injury, varicocele, and idiopathic infertility.

Urol J., 3(1):32-7, Winter 2006 [PMID: 17590850]

54. Pourmand G, Pourmand M, Salem S, Mehrsai A, TaheriMahmoudi M, Nikoobakht M,

Ebrahimi R, Saraji A, Moosavi S, Saboury B. Posttransplant infectious complications: a

prospective study on 142 kidney allograft recipients. Urol J., 3(1):23-31, Winter 2006

[PMID: 17590849]

55. Mehrsai A, Mousavi S, Nikoobakht M, Khanlarpoor T, Shekarpour L, Pourmand G.

Posttransplant infectious complications: a prospective study on 142 kidney allograft

recipients. Urol J., 3(4):240-4, Fall 2006 [PMID: 17559049]

56. Djaladat H, Mehrsai A, Nasseh H, Pourmand G. Synchronous renal fossa recurrence with

bladder metastases due to renal cell carcinoma. Urol J., 2(3):169-70, Summer 2005[PMID:

17602423]

57. Mehrsai A, Djaladat H, Sina A, Salem S, Pourmand G. Buccal mucosal graft in repeat

urethroplasty. Urol J., 2(4):206-10, Autumn 2005 [PMID: 17602431]

58. Pourmand G, Nasseh H, Sarrafnejad A, Mehrsai A, HamidiAlamdari D, Nourijelyani K,

Shekarpour L. Urinary Tamm-Horsfall protein and citrate: A case- control study of

inhibitors and promoters of calcium stone formation. Urology Journal, 2(2):79-85,

Spring 2005 [PMID: 17629875]

59. Pourmand G. Molecular detection of prostate specific antigen in patients with prostate

cancer or benign prostate hyperplasia the first investigation from Iran. Iranian Journal

of Public Health, Vol. 34(3): 20-26, 2005

60. Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers with

erectile dysfunction benefit from stopping? A prospective study. BJU International,

94(9):1310-3, December 2004 [PMID: 15610111]

61. Pourmand G. Preliminary report of a nationwide case-control study for indentifying

risk factors of tuberculosis following renal transplantation. Transplantation

Proceedings, 37(7): 3041-4, September 2005

62. Nikbin B., Tajik N., Saraji A, Pourmand G, Talebian F., Mehrsai A., Amirzargr A.

Microchimerism & renal transplantation: Doubt still persists.IJI. Vol. 1, No. 3, Autumn

2004

63. Mehrsai A, TaghizadehAfshar A, Zohrevand R, Djaladat H, Steffes H, Hesse A,

Pourmand G. Evaluation of urinary calculi by infrared spectroscopy. Urology Journal,

1(3):191-4, Summer 2004[PMID: 17914687]

64. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three

trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004

65. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three

trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004

66. Pourmand G. Comparison between clinical and pathologic staging in patients with

bladder cancer. Urology Journal, Vol. 2, 85-89, Spring 2004

67. Pourmand G. Management of Peyronie’s disease by dermal grafting. Urology Journal,

Vol. 2, 99-102, Spring 2004

68. Pourmand G. Effect of renal transplantation on sperm quality and sex hormone levels.

BJU international, Vol. 92, 281-283, 2003

69. Pourmand G. Effect of grapefruit juice on serum concentration of cyclosporine in

Iranian renal transplant patients. Transplantation Proceedings, 35: 2739-2741, 2003

70. Pourmand G. Outcome of 18 cases of simultaneous kidney and donor- specific bone

marrow transplantation. Transplantation Proceedings, 35: 2761-2762, 2003

71. Pourmand G. Omission of azathioprine and mycophenolatemofetil in

immunosuppressive regiment in kidney transplantation. Transplantation Proceedings,

35: 2752-2753, 2003

72. Pourmand G. Prevalence of Y chromosome microdeletions in Iranian infertile men.

Acta Medica Iranica, Vol. 41, No.3, 164-169, 2003

73. Pourmand G. Prospective study of microchimerism in renal allograft recipients:

association between HLA DR matching, microchimerism and acute rejection. Kidney

Transplantation, 15:192-198, 2001

74. Pourmand G. Impact of donor nephron mass on outcomes in renal transplantation.

Transplantation Proceedings, 33: 2828-2829, 2001

75. Pourmand G. Evaluation of endourological interventions used to treat urological

complications in 394 kidney recipients. Transplantation Proceedings, 32(3): 524-5, May

2000

76. Pourmand G. Patient blood Glucose levels before and after kidney transplantation.

Transplantation Proceedings, 32(3): 566-8, May 2000

77. Pourmand G. The prevalence of infected stones in the urinary tract and their

relationship to urease positive bacteria. Journal of Nep-urol and transplantation, Vol. 1.

No. 1. (5-8), January 2000

78. Pourmand G. Evaluation of the clinical and urodynamic effects of pygeumafricanum

(tadenan) in the treatment of benign prostatic hyperplasia (BPH). British Journal of

Urology, 1997; 80 (Suppl.2), p.227

79. Pourmand G. Traumatic rupture of penile tunica albuginea: management and impact

on erectile function. British Journal of Urology; 80 (Suppl.2), p.99, 1997

80. Pourmand G. Bacteriuria and extracorporeal shock wave lithotripsy, prophylaxis and

treatment. British Journal of Urology; 80 (Suppl.2), p.332, 1997

81. Pourmand G. Evaluation of acute kidney rejection in 151 recipients. British Journal of

Urology 80, (Suppl.2), p.147, 1997

82. Pourmand G. Extracorporeal shock wave lithotripsy in horseshoe kidneys. British

Journal of Urology; 80 (Suppl.2), p.333, 1997

83. Pourmand G. Congenital Ureteric Valve associated with renal dysgenesis. British

Journal of Urology, Vol.61. 362-363, April 1988

84. Pourmand G. Evaluation of surgical complications in 151 transplanted kidneys.

Transplant proceedings, 1998

85. Pourmand G. Twenty two Cases of simultaneous heart, liver and kidney transplant

from established brain dead patients. Transplant proceedings, 30 773-774, 1998

86. Pourmand G. Lipids and lipoproteins alteration after renal transplantation.

Nephrology Dialysis Transplantation. 12 (1): 233-4, January1997

87. Pourmand G. Nocardiosis: Report of four cases in renal transplant recipients.

Transplantation Proceedings Vol. 27, No.5:2731-2733, October 1995

88. Pourmand G. Urinary tract obstruction following ESWL. Acta Medical Iranica, Vol.

32: No. 1 (22) 1-11, 1994

89. Pourmand G. Laparoscopy in Urology. Acta Medical Iranica, Vol. 32, 101-109, 1994

90. Pourmand G. Kibrick test in Vasovasectomy, ACTA Medical IRANICA, 1992

91. Pourmand G. Donor polar kidney arteries: experience with 10 cases among 140 living-

related kidney transplants. Transplantation Proceedings. 24(5):1867, October 1992

92. Pourmand G. The mineral compositions of 103 stones from Iran. British Journal of

Urology, Vol. 55 No.5, October 1983

Farsi

93. Pourmand G. The Effect of Renal Transplantation on Improvement of Erectile

dysfunction in hemodialysis patients. Urmia Medical Journal. Vol. 18, No. 3, Fall 2007:

567-571

94. Pourmand G. Design, fabrication and test of a new self-retaining, standing, adjustable

surgical retractor for abdominal and thoracic surgical operations. Hakim Research

Journal 2007; 9(4): 37-45

95. Pourmand G. Post-Transplantation infectious complication in Iranian kidney

recipients: A prospective study of 142 patients. Scientific Journal School of Public

Health and Institute of Public Health Research, Vol. 4, No. 2, Summer 2006

96. Pourmand G. Response of T cell cytokines to low level He-Ne laser irradiation invitro:

can low level lasers prevent chronic graft rejection? Lasers in Medicine, Vol.4, No. 4,

Spring 2006

97. Pourmand G. Evaluation of bone mineral density in patients with urolithiasis.

Hormozgan Medical Journal No 3, Fall 2005: 157-162

98. Pourmand G. Hematospermia. Medical Journal of Tehran Medical School, Spring 2004

99. Pourmand G. Clinical and laboratory findings of CMV infection in renal transplant

recipients in Sina Hospital. Journal of infectious and tropical diseases.2003:37-39

100. Pourmand G. Post kidney transplantations: Infectious complications. Today

Iranian Journal of Urology, 16-23, 2003

101. Pourmand G. Genes and gene therapy in oncourology. Iranian Journal of Urology,

Spring 2001

102. Pourmand G. Success rate of ICSI in non-obstructive Azoospermia. No. 32: 183-

189, Autumn 2001

103. Pourmand G. Evaluation of frequency or aggravation of diabetes mellitus after

renal transplantation in Sina Hospital. Iranian Journal of Endocrinology &Metabolism ,

3, No. 2, Summer 2001

104. Pourmand G. Micro-chimerism in allograft renal recipients: A prospective study.

Iranian Journal of Urology, Winter 2001

105. Pourmand G. Comparison of sperm quality and sex hormone levels in patients

before and after renal transplantation. Iranian Journal of Endocrinology & Metabolism,

2, No. 4, Winter 2000

106. Pourmand G. Splenosis presenting as an adrenal mass. Iranian Journal of Urology,

No. 27, Fall 2000

107. Pourmand G. Impact of varicocelectey on strict morphology criteria. Iranian

Journal of Urology, No. 25, Spring 2000

108. Pourmand G. Role of urease positive bacteria on infected urinary tract stone

Formation. Journal of infectious and tropical diseases, Winter 1996: 34-39

109. Pourmand G. The 1st clinical report of ESWL in Iran. Journal of Medical Council,

1992

110. Pourmand G. Pheochromocytomain bladder, Medical Journal of Islamic Republic

of Iran, Vol.21. 75-77:1988

111. Pourmand G. Spectroscopy of renal stones in Iran. Journal of Iranian Medical

Council. Vol.9.14-24:1984

112. Pourmand G. Congenital Urethral Diverticulum along with paraurethral diver.

Journal of Tehran Medical School, Vol. 5-6, 95-98, 1981

113. Pourmand G. Ectopic ossification as a nidus for renal stone. Journal of Iranian

Medical Council, Vol 6.467:1978

Books

1. Pourmand G, Pourmand B. AChapter on" Epidemiology of Stone Disease in Iran".

(Book Title: Urolithiasis), Springer-Verlag London, DOI 10.1007/978-1-4471-4387-

1_11, 2013

2. Pourmand G. An Overview of Urology in 50 Years. Sharif Publications, 2012

3. Soleimani A, Pourmand G. Sina Hospital: From Past to Present. Sina University

Hospital Publications, 2012

4. Pourmand G. Iranian Textbook of Urology. Shahid Beheshti University Publications,

2007

5. Pourmand G. Essential Urology. Tehran University of Medical Sciences Publications,

2003

6. Pourmand G. Organ Transplantation. Special Diseases Center, 2003

7. Pourmand G. Organic Causes of Male Impotency. Tehran University of Medical

Sciences Publications, 1994

Presentations in National & International Meetings

1. September 08 – 12, 2013: 33rd

Congress of the Societe Internationale d'Urologie,

Vancouver – Canada

a. Modified cutoff point of total prostate-specific antigen and free-ti-total

prostate-specific antigen ratio for detecting prostate cancer: sensitivity and

specificity evaluation (Moderated poster)

b. The association between androgenic hormone levels and the risk of

developing coronary artery disease (Moderated poster)

c. Does antioxidant therapy add any benefit in improvement of DNA

fragmentation to standard inguinal varicocelectomy? A randomized case-

control study (Moderated poster)

d. Pretest probability of prostate cancer for patients undergoing prostate biopsy

(Poster)

e. High uric acid serum level as a predictive factor of erectile dysfunction in

coronary artery diseases (Poster)

f. Serum calcium as a protective marker against prostate cancer: Role of

associated factors (Poster)

2. November 18, 2012: 3rd

International Medical Congress: Newest Research

Achievements in Clinical & Molecular Medicine (Medical Ethics & History), Clinical &

molecular image of prostate cancer in Iran, Tehran – Iran

3. September 30 – October 04, 2012: 32nd

Congress of the Societe Internationale

d'Urologie, Fukuoka – Japan

a. Effects of Testosterone administration sexual function in aging males with

symptoms of late-onset hypogonadism and normal or subnormal Testosterone

level: A comparative study (Moderated poster)

b. Effectiveness of transdermal electromotive versus intralesional injection of

Verapamil and Dexamethasone in treating Peyronie's disease (Moderated poster)

c. Interstitial cystitis associated with neuromyelitis optica (Electronic poster)

d. Relationship between post-kidney transplantation anithymocyte globuline

therapy and wound healing complications (Electronic poster)

e. Uterovesical fistula (Video presentation)

4. May 24, 2012: Weill Cornell Medical College, Epidemiology of prostate cancer in Iran,

New York – USA

5. May 19-23, 2012: Annual Meeting of the American Urological Association(AUA),

Serum calcium as a protective marker against prostate cancer: Role of associated

factors, Atlanta, GA – USA (Moderated poster)

6. May 10-13, 2012: 15th

Congress of Iranian Urological Association, Tehran – Iran

a. Effectiveness of transdermal electromotive versus intralesional injection of

Verapamil and Dexamethasone in treating Peyronie's disease

b. Testosterone administration effects on sexual function in aging males with

symptoms of late-onset hypogonadism and normal or subnormal testosterone

level: a comparative analysis

c. Relationship between post kidney transplantation Antithymocyte Globuline

therapy and wound healing complications

d. Interstitial Cystitis associated with Neuromyelitis Optica

e. Hydatid cyst of Adrenal Gland

f. Serum trace elements before and 3 months after renal transplantation in kidney

recipients at Sina Hospital in 2010

7. April 18-20, 2012:18th

National Congress of Iranian Society for Reproductive Medicine

Spontaneous Abortion & Male Factor, Tabriz – Iran

8. November 8-11, 2011: 9th

International Congress on Obstetrics & Gynecology, Stem cell

application in SUI management, Tehran – Iran

9. September 7-10, 2011: 1st Meeting of EAU Section of Urolithiasis (EULIS), London –

UK

a. Stones in the East (Poster)

b. Training the academic stone doctor

c. Epidemiology of stone disease in developing countries

10. July 13, 2011: Seminar on Executive Solutions for Cancer Control in Iran, Solutions

offered by TUMS Urology Research Center, Vienna – Austria (Poster)

11. May 14-19, 2011: Annual Meeting of the American Urological Association,

Washington DC – USA

a. HER2/NEU overexpression as a prognostic factor in urothelial carcinoma of

the bladder: A comparative analysis

b. Role of steroid hormone receptors on formation and progression of bladder

carcinoma

c. Serum uric acid ad an independent risk factor for erectile dysfunction

12. May 3-6, 2011: 14th

Congress of Iranian Urological Association, Tehran – Iran

a. A prospective evaluation of graft rejection episodes by Doppler resistance

indices in kidney recipients

b. Augmentation of Chimerism by donor bone marrow cells infusion in kidney

allograft recipients

c. Dyslipidemia in kidney transplantation recipients: Evaluation of risk factors

d. Extraperitoneal orthotopic radical cystoprostatectomy approach can improve

the postoperative morbidity

e. Is antithymocyte therapy considered as risk factor for post kidney

transplantation cytomegalovirus infection?

f. Is there a relation between post-kidney transplantation antithymocyte globulin

therapy and wound healing disturbance?

g. Modified cut-off point of total prostate-specific antigen and free-to-total

prostate-specific antigen ratiofor detecting prostate cancer: sensitivity and

specificity evaluation

h. Sandwiched tunnel: A novel antireflux ureterointestinal pouch anastamosis

approach with easier endourologic access

i. Serum calcium as a protective marker against prostate cancer: Role of

associated factors

j. Serum calcium concentration, sex steroid hormones and risk of prostate

cancer: A prospective evaluation

k. Serum uric acid as a risk predictor for erectile dysfunction severity

l. Sex hormones, sexual activity and risk of prostate cancer: A multicenter study

m. Sex steroid hormones play pivotal roles in the diabetes mellitus effects on

prostate cancer risk

n. Testosterone administration effects on sexual function in aging males with

symptoms of late-onset hypogonadism and normal or subnormal Testosterone

level: A comparative analysis

o. Would calcium consumption lead to a reduction in the prevalence of prostate

cancer?

13. March 18-22, 2011: 26th

Annual EAU Congress, Kidney transplantation: Basic

research and technical risks , Vienna – Austria (Poster)

14. April 09, 2011: Nexavar RCC Expert Workshop, Paris – France

15. November 07-11, 2010: Women's Congress, Role of male factor in infertile patients,

Tehran – Iran

16. November 02, 2010: Educational workshop on devising local values for specialized

urological services, Tehran – Iran

17. September 27-29, 2010: Workshop for familiarizing new residents of Sina Hospital

(2010-2011), Tehran – Iran

18. October 18-21, 2010: The 12th

Congress of the Middle East Society for Organ

Transplantation, Tunis – Tunisia

19. June 30 – July 02, 2010: ISN Nexus Symposium on Fibrosis & the Kidney, CKD

prevalence in rural population of over 30 years in Shahreza in 2009,Geneva –

Switzerland

20. June 24, 2010: Sanofi-Aventis Prostate/Breast Cancers Standalone, Panel & Case

Discussion, Budapest – Hungary

21. June 22, 2010: Iranian Cancer Association, Panel & Case Discussion, Tehran – Iran

22. May 13-16, 2010: The26th

Iranian Congress of Radiology, Tehran – Iran

a. Renal Masses

b. Panel: Diagnostic clues and pitfalls in Uroradiology

23. May 13-16, 2010: 13th

Congress of Iranian Urological Association, Tehran – Iran

a. Serum triglyceride concentration and prostate cancer risk: A multicenter

study

b. Evaluation of serum high-sensitivity C-reactive protein in kidney transplant

recipients within the first six months after transplantation

c. Evaluation of urologic and non-urologic complications of cesarean section

delivery compared to natural vaginal delivery in patients referred to Arash

Hospital

d. Evaluation of underlying risk factors for delay in referring children with

urethral tract infections (Utis) to hospitals

e. Her-2 oncogen expression and risk of bladder cancer: Role of associated

factors

24. May 2010: The34th

Annual Congress of the Iranian Surgeons Society& the 9th

Iranian

Organ Transplantation Scientific Congress, Tehran – Iran

a. Round table: Preparing and removing transplanting organs

b. Imaging in Organ Transplantation

25. April 16-20, 2010: Annual EAU Congress, Barcelona – Spain

a. PTEN gene mutation & primary prostate cancer progression

b. Participation in the Joint Session: Low risk prosthetic carcinoma: Surgery or

surveillance?

26. 2008: Iranian Congress of Renal Transplantation

a. Management of ureteral urologic complications: experience after 1000 kidney

transplantation

b. Does PTN gene play a role in prostate cancer progression?

c. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow

transplantation

d. Does donor nephron mass have any impact on graft survival?

e. Microchimerism and renal transplantation: Doubt still persists.

f. Surgical techniques in treatment of urologic complication after renal

transplantation

g. Pelvic Nerve neuropathy after kidney transplantation

h. The effect of successful renal transplantation on erectile dysfunction

i. Omission of azathioprine and mycophenolatemofetil in

immunosuppressive regimen in kidney transplantation

j. Effect of renal transplantation on sperm quality and sex hormone level

k. The outcome of renal transplantation in 28 patients receiving kidneys with

multiple renal vessels

l. Effect of donor bone marrow cells infusion on alloimunization and kidney

allograft outcome

m. Infectious complications in 142 Persian kidney transplant recipients during

one-year follow-up

27. 2008:The 7th

Congress of Iran Organ Transplantation

a. The effect of Successful Renal Transplantation on erectile dysfunction.

b. The effect of Successful Renal Transplantation on Sperm quality and sex

hormones level.

c. Post kidney transplantation hepatitis C virus and its impact on graft and

patient survival.

d. Does donor nephron mass have any impact on graft survival?

e. Surgical techniques in treatment of urologic complication after renal

transplantation.

f. Infectious complications in 142 persiankidney transplant recipients during one

year follow-up

g. Effect of living unrelated donor bone marrow cells infusion on kidney allograft

function.

h. Ureteroscopic management of urological complications after renal

transplantation.

28. 2008: The11th

Congress of Iranian Urological Association

a. Serum Selenium level and prostate cancer: A case-control study

b. The effect of low level he-ne laser radiation (4 j/cm2) 632.8 nm on the

secretion of effective cytokine on chronic graft rejection: An invitro study

c. Effect of living unrelated donor bone marrow cells infusion on kidney

allograft function

d. Management of ureteral urologic complications: experience after 700 kidney

transplantation

e. Post kidney transplantation hepatitis C virus and its impact on graft and

patient survival

f. The effect of calcium, magnesium, zinc and copper in blood and seminal

plasma on semen parameters of spinal cord injured men

g. Serum Leptin level and premature ejaculation: A case-control study

h. TUL or ESWL is the approach of choice for upper ureter stones management:

a comparative study

29. 2008: The23rd

Annual EAU Congress, Extracorporeal shock wave lithotripsy in

adults: results and short-term complications, Milan – Italy

30. 2008: AUA 2008 Annual Meeting (USA)

a. Extracorporeal shock wave lithotripsy and its effect on renal function,

assessed by 99m Technetium Dethylene-Tiamine-Pentaacetic acid

Scintigraphy

b. The effect of successful renal transplantation on erectile dysfunction

a. 2008: The 2nd

International Congress of Medical Ethics in Iran, Ethical

consideration for kidney transplant from deceased patients

31. 2007: The 29th

Congress of the Societe International d’urologie (SIU) (Paris –

France)

a. Serum selenium level and prostatecancer: A case-control study

b. TUL or ESWL is the approach of choice for upper ureter stones management:

a comparative study

c. The effect of successful renal transplantation on erectile dysfunction.

32. 2007: EAU 1st Eastern Mediterranean Meeting (Antalya – Turkey)

a. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow

transplantation

b. Serum selenium level and prostate cancer: A case –control study

c. Does PTN gene play a role in prostate cancer progression?

d. Anabolic androgenic steroids effects on early morbid symptoms after open

prostatectomy

e. Prospective study of michrochimerism in renal allograft recipients:

Association between HLA-DR matching, michrochimerism and acute rejection

f. Effect of renal transplantation on sperm quality and sex hormone level

g. The effect of low level He-Ne laser radiation (4J/cm2)632.8nm on the

secretion of effective cytokine on chronic graft rejection-an in vitro study

h. Microchimerism and renal transplantation: Doubt still persists

i. Post kidney transplant hepatitis C virus and its impact on graft and

patient survival

j. Does donor nephron mass have any impact on graft survival?

k. Urinary tamm-horsfall protein and other inhibitors and promotors of calcium

stone formation: A case-control study

l. TUL or ESWL is the approach of choice for upper ureteral stones

management: A comparative study

m. Evaluation of sperm nuclear chromatin condensation in infertile patients

with spinal cord injury varicocele and healthy individuals

33. 2007: The 13th

Congress of The European Society for Organ Transplantation (ESOT)

a. Surgical techniques in treatment of urologic complication after renal

transplantation

b. Does donor nephron mass have any impact on graft survival?

c. Improvement of erectile dysfunction after kidney transplantation the role of

associated factor

d. Effect of living unrelated donor bone marrow cells infusion of kidney allograft

function

e. Post kidney transplant hepatitis C virus and its impact on graft and patient

survival

f. Role of resistive index measurement in diagnosis of acute rejection after renal

transplantation

34. 2007:The19th

Asia Pacific Cancer Congress, Screening for prostate cancer, Tehran –

Iran

35. 2007: The 44th

ERA-EDTA Congress (Barcelona, Spain)

a. Prevalence of metabolic abnormalities of calcium in pateints with urinary

stone in south Iran

b. Effect of renal transplantation on sperm quality and sex hormones level

c. Prospective study of microchimerism in renal allograft recipients: Association

between HLA DR matching, microchimerism and acute rejection.

d. Role of resistive index measurement in diagnosis of acute rejection after renal

transplantation.

e. Ureteroscopic management of urological complications after renal

transplantation

36. 2007: The7th

International Congress on Obstetrics and Gynecology, Nanogyncology,

Iran

37. 2007: The 11th

International Congress of Nephrology, Dialysis and Transplantation,

Iran

a. Effect of living unrelated donor bone marrow cells infusion on kidney

allograft function

b. Post kidney transplant hepatitis C virus and its impact on graft and patient

survival

38. 2007: The 10th

Iranian Urological Ass. Congress, TUL or ESWL is the approach of

choice for upper ureteral stones management: A comparative study

39. 2007:Vascular Surgery and Diabetics Mellitus Congress, Diabetes and kidney

transplantation, Tehran – Iran

40. 2007:XLIV-EDTA Congress (Spain), Prospective study of microchimerism in renal

allograft recipients: Association between HLA DR matching, microchimerism and

acute rejection

41. 2006:The10th

Congress of the Middle East Society for Organ Transplantation, Kuwait

a. The effect of successful renal transplantation on erectile dysfunction

b. Surgical techniques in treatment of urologic complication after renal

transplantation

42. 2006: The 28th

Congress of the Societe Internationale d’Urologie, South Africa

a. Seminal plasma magnesium and premature ejaculation: a case-control study

b. Does PTEN gene play a role in prostate cancer progression?

c. The impact of nandrolone on post prostatectomy bothersome symptoms

d. Comparison of urinary proteins in calcium stone formers and healthy

individuals: a case-control study

e. Ureteroscopic management of ureteral injury during gynecological surgery

f. Preoperative corporal biopsy can predict postoperative results in

venoocclusive erectile dysfunction

g. The relationship between lipid profile and erectile dysfunction

43. 2006: The 21st Congress of the European Association of Urology (EAU),

Microchimerism and Renal Transplantation: Doubt Still Persists, Paris – France

44. 2006: The 31st Congress of the Federation-of-European-Biochemical-Societies

(FEBS) Istanbul, Turkey

a. Prevalence intron 1 duplication among patients susceptible to primary

hyperoxaluria type 1 in Iran

45. 2006: The10th

Iranian Annual Congress of Nephrology, Dialysis and

Transplantation

a. A nationwide case-control study for identifying the risk factors for

tuberculosis following renal transplantation

b. Guillan - Barre Syndrome after renal transplantation

46. 2006: The Iranian Medical Students Nano Congress Seminar. Applied Nano Medicine

47. 2006: The 43rd

Annual congress of the European-Renal-Association/ European-

Dialysis-and-Transplant Association (ERA-EDTA) Glasgow, Scotland

a. Outcome of 18 cases of simultaneous kidney and donor- specific bone marrow

transplantation.

b. Endourological interventions used to treat urological complications in 700

kidney recipients.

c. Prospective study of microchimerism in renal allograft recipients.Association

between HLA DR matching, microchimerism and acute rejection

d. Prevalance of metabolic abnormalities of calcium in pateints with urinary

stone in south Iran

e. Omission of azathioprine and mycophenolatemofetil in immunosuppressive

regimen in kidney transplantation

f. Incidence of post renal Transplantation hyperlipidemia and its long term

impact on patients and graft survival

g. Effect of renal transplantation on sperm quality and sex hormones level

48. 2005:The 42nd

Annual Congress of the European-Renal-Association/ European-

Dialysis-and-Transplant Association (ERA-EDTA), Istanbul, Turkey

a. Effect of donor kidney mass on graft survival in renal transplantation

b. Prevalence of metabolic abnormalities of calcium in patients with urinary

stone in south Iran

c. Prospective study of microchimerism in renal allograft recipients: Association

between HLA DR matching, microchimerism and acute rejection.

d. Effect of renal transplantation on sperm quality and sex hormones level

49. 2005: Nano Medicine in Obstetrics & Gynecology

50. 2005: The General Secretary of Energy in Endourology

51. September 13 – 15, 2005:The 9th

European Symposium on Urolithiasis, Rotterdam –

The Netherlands

a. The Infrared Spectroscopic Analyses of 241 Iranian Urinary Stones

b. Comparison of Urine Culture Proximal to Stone with Preoperative Urine

Culture

52. March 16 – 19, 2005:The XXth

Congress of the European Association of Urology,

Istanbul – Turkey

a. Catheter-free suprapubicprostatectmy: a novel technique

b. Effect of donor kidney mass on graft survival in renal transplantation

c. Do cigarette smokers with erectile dysfunction benefit from quitting?

d. Selective Evaluation of two urinary enzymes (NAG and AAP) before and after

unilateral shock wave lithotripsy

53. October 3 – 7, 2004: The Xth

Congress of the Societe Internationale d'Urologie

(SIU), Hawaii – USA

a. Urinary Tam-Horsfall protein, inhibitors and promoters of calcium stone

formation: a case- control study

b. Ras and p53 gene mutations in Iranian bladder cancer

c. Erectile dysfunction in patients with coronary artery disease

d. Role of resistive index measurement in diagnosis of acute rejection after renal

transplant

e. The effect of electroejaculation on the quality and quantity of seminal fluid

and sperm of spinal cord injured (SCI) men in comparison with normal fertile

men

f. Endourological interventions used to treat urological complications in 700

kidney recipients

g. VII- Clinical correlation of unilateral testicular hypotrophy and semen quality

h. Relation between erectile dysfunction and blood lipids: a case- control study

54. 2004: AUA 2004 annual meeting (San Francisco,CA)

a. Bone mineral density evaluation in urolithiasis

55. 2004:The 9th

International Congress of the Middle East society for organ

transplantation, Ankara – Turkey

a. Omission of azathioprine and mycophenolatemofetil in immunosuppressive

regimen in kidney transplantation

b. Preliminary report of a nationwide case control study for identifying the risk

factors of tuberculosis following renal transplantation

c. Microchimerism and renal transplantation: doubt still persists

d. To study the risk factors for post- transplant diabetes mellitus

56. April 22 – 24, 2004:The 9th

International Congress of the Middle East Society for

Organ Transplantation, Tehran – Iran

a. Post kidney transplant Hepatitis C virus and Its impact on graft and patient

survival

b. Surgical Techniques in Treatment of Urologic Complications

c. Kidney transplantation and diabetes mellitus

57. 2003: Genetics in urology. The 1st Iranian International Congress on Medical

Genetics

58. 2003: Arbiter in the 9th

Razi Medical Research Festival

59. September 21 – 24, 2003:The 11th

Congress of the European Society for Organ

Transplantation,VeniceLido – Italy

60. September 20 – 22, 2003:The 13th

Congress of the European Transplant

Coordinators Organization,VeniceLido – Italy

61. 2003:EUA,Madrid – Spain

62. 2003:EDTA Congress,Denmark

63. 2002: Arbiter in the 8th

Razi Medical Research Festival

64. 2002: Physician and forensic medicine. The International Congress on Forensic

Medicine

65. September 8 – 12, 2002:The 26th

Congress of the Societe Internationale d’ Urologic,

Stockholm – Sweden

a. Prospective study of microchimerism in renal allograft recipients. Association

between HLA DR matching, microchimerism and acute rejection

b. Kidney transplantation and diabetes mellitus

c. Effect of renal transplantation on sperm quality and sex hormones level and

sexual function

d. Evaluation of endourological intervention used to treat urological

complications in 394 kidney recipients

e. Effect of sex of donor blood group and age difference between donor and

recipient on early acute rejection in 370 renal transplantations

66. October 21 – 24,2002:The VIII International Congress of the MESOT, Oman

67. September 8 – 12,2002: The 26th

SIU, Stockholm – Sweden

68. September 13-15, 2001:The 9th

European Symposium on Urolithiasis, Rotterdam –

The Netherlands

a. Comparison of Urine Culture Proximal to stone with preoperative urine

culture

b. The Infrared Spectroscopic Analyses of 209 Iranian urinary stones

c. Prevalence of metabolic abnormalities of Calcium in patients with urinary

stone in South of Iran

d. Effect of nasal desmopressin on the treatment of acute renal colic

69. 2001:International Congress of the Middle East Society for Organ Transplantation,

Stockholm – Sweden

a. Patient blood glucose levels before and after kidney transplantation

b. Incidence of post renal Transplantation hyperlipidemia and its long term

impact on patients and graft survival

c. Evaluation of endourological interventions used to treat urological

complications in 394 kidney recipients

d. The outcome of renal transplantation in 23 patients receiving kidneys with

aberrant or accessory vessels

e. Impact of donor Nephron mass on outcome in renal transplantation

f. Alternations in standard immunosuppressive regimen in kidney transplanted

patients and its effects on graft survival

g. Post kidney transplant hepatitis C Virus and its impact on graft and patient

survival

70. 2001-02: Workshop on Scientific Writing

71. 2001:25 years in Renal Transplantation, Ankara – Turkey

72. 2001:The European Association of Organ Transplantation, Lisbon – Portugal

73. 2001: Premature Ejaculation. The 5th

Iranian Urological Association Congress

74. 2001: Gene therapy in Urological Cancers. The 6th

Iranian Urological Association

Congress

75. 2000: Infection in children. The Iranian Congress on Urinary Infection in Newborns

and children

76. 2000:Middle East Organ Transplantation Congress, Beirut – Lebanon

77. 1999:Middle East Organ Transplantation Congress, Isfalan – Iran

78. 1999:The 8th

Urolithiasis Symposium, Parma – Italy

79. 1999:The First Iranian Organ Transplantation Congress, Iran

80. 1999:The 23rd

Congress of SIU, Sydney - Australia

81. 1999:The 4th

International Urological Congress, Iran

82. 1999:The 25th

Congress of the Societe Internationale d’ Urologie, Stockholm –

Sweden

a. Chromosomal studies of 222 infertile males in Tehran

b. Intra-Cytoplasmic Sperm Injection for Non-obstructive Azoospermia

83. 1998:Update in Nephrology Course, Dubai – UAE

84. 1997:The 4th

Turkish Organ Transplant, Ankara – Turkey

85. 1997:The 24th

Congress of the Societe Internationale d’ Urologic, Montreal – Canada

a. Evaluation of Acute kidney Rejection in 151 Recipients

b. The Incidence of Infected Stones and their Relationship to Urease Positive

Bacteria

86. 1997:The 15th

World Congress on Endourology, Edinburgh – Scotland, UK

a. Evaluation of the Clinical and Urodynamic Effects of pygeum Africanum

(TADENAN) in the Treatment of Benign Prostatic Hyperplasia (BPH)

b. Utilizing of N-Acetyl-Glucosaminidase (NAG) & Alanin Aminopeptidase

(AAP) Urinary Enzymes to Evaluate Kidney Parenchymal Injury Following

Extracorporeal Shock wave Lithotripsy (ESWL)

87. 1997:Nuclear Scintigraphy EAU Congress, Paris – France

a. The Early Effect of Electromagnetic Lithotripsy on Renal Function Assessed

by Nuclear Scintigraphy EAU Congress

b. Traumatic Rupture of Penile Tunica Albuginea: Management and impact on

Erectile Function, EAU Congress Paris, France

88. 1996:The Xllth

EAU Congress, Paris – France

89. 1996:Visiting the Nephrology Department of PISA University, Italy

90. 1996:The 5th

Middle East Society for Organ Transplantation, Lipid and Lipoproteins

alterations after Renal Transplantation, Limassol – Cyprus

91. 1994: Xth

World Congress of Endourology, Louisiana – USA

a. Bacteriuria and Extracorporeal shock wave lithotripsy Prophylaxis and

treatment

b. Extracorporeal shock wave Iithotripsy in Horseshoe kidneys

92. 1992: Xth

Congress European Ass. Urology, Early Repair of Urological injuries

following pelvic Surgery, Italy

93. 1992: Xth

Congress of European Ass. Urology, Italy

94. 1991:Ethics, Justice & Commerce in Organ Transplantation, Munich – Germany

95. 1991: 22nd

International Urological Congress, Complex Post. Urethral Stricture,

Servilla - Spain

96. 1990: Middle East Organ Transplantation, Urological Complications in Transplanted

Kidneys, Mesot–Kuwait

97. 1990:The 2nd

International Urological Seminar, Tubed Versus Tubeless Pyeloplasty,

Tabriz – Iran

98. 1989:The 3rd

Annual Avicenna Medical Congress, Management of Urological

Complications in Kidney Transplant, Tehran – Iran

99. 1989:Lithotripsy Meeting, Dubai – UAE

100. 1988:American Urological Association (Annual meeting), Dallas – USA

101. 1988: The 2nd

Annual Avicenna Medical Congress, Ureteral folding versus

Ureteral tailoring in management of megaureter, Tehran –Iran

102. 1987: The 1st International Urological Seminar,Omental Graft in complicated

vesicovagingl fistulae, Tehran – Iran

103. 1987: The 1st International Urological Seminar, Evaluation of Transpublic

Urethroplasty, Tehran – Iran

104. 1986: The 1st Annual Avicenna Medical Congress, Ureteral folding versus

Ureteral tailoring in management of megaureter, Iran

105. 1977:The British Association of Urological Surgeons, Aberdeen – UK

Grants:

Completed Grants

Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy

volunteers and Renal Transplant recipients (September 4, 2005 – July 10, 2006) with

ZahraviPharma Company

Pending Grants

Result of prostate biopsy on the basis of Total PSA (free PSA , PSA D) accompany

with prostate cancer risk factors , in Iranian patients ( September 23, 2007 up to

now) with Ministry Of Health and Medical Education

Awards:

International Award of Excellence in Medical Sciences, The Highest International

Prof. Yalda Award for Distinguished Teaching, Research, Ethical & Social

Responsibility in Medical Sciences (Medal of Honor & Trophy), November 2012

2nd

Royan International Research Award

Special Diseases Foundation “Letter of Appreciation”

Shiraz Janbazan Organization “Letter of Appreciation”, Supervisor of the Examining

Board (Ministry of Health and Medical Education)

7th

Razi Festival Award (National Research Center of Medical Sciences), First Rank –

Clinical Sciences

The 11th

Razi Festival Award, First Rank – Invention, Innovation, Novelty and

Scientific Hypothesis

Competencies:

Language

o Moderate English